Watch this incredible video of a patient with venous thoracic outlet syndrome. Provocative testing shows right subclavian compression and compromised venous return—you can even see flow reversal refluxing up the neck!
Courtesy: @paulgamboad#FOAMed
ERJOR: This nationwide real-world study uses high-resolution data to document that elexacaftor/tezacaftor/ivacaftor halts progression of lung disease in cystic fibrosis, and improves lung function across all ages, disease severities and prior modulator use https://t.co/Y5g00tYKh0
What impact has Elexacaftor/Tezacaftor/Ivacaftor had on death & lung transplant rates for eligible recipients with advanced #CF lung disease? >90% reduction according to a study from researchers
@UBC@HLIStPauls@ucddublin@CFCanada@UofT & @DalhousieU
https://t.co/5O8SmvB23C
A great #ERS2024 for @ucddublin. One #ERS president, one incoming #ERS treasurer, multiple session chairs and oral presentations, and over 20 poster presentations. Thanks you to @EuroRespSoc and #Vienna @irishthoracicS
Ryan Donnelly from @ucddublin presenting results from his late breaking abstract at #ERS2024. “Deciphering disagreement. Sarcoidosis management and the role of FDG-PET/CT.” @EuroRespSoc @irishthoracicS
Congratulations to UCD School of Medicine’s Professor Adam Byrne and all the team on their recently published research on Type 1 Invariant Natural Killer T Cells Drive Lung Fibrosis in the American Journal of Respiratory and Critical Care Medicine. More: https://t.co/qpaTpL7emA
Reviewing the evidence of aberrant lipid metabolism in idiopathic pulmonary fibrosis. A possible future therapeutic avenue? https://t.co/oBiFxPsvWM #IPF@AJRCMB
Congratulations to Prof. Cormac McCarthy on winning the @ErnLung Academy Webinar of the year as voted by the graduates - Cormac is a member of @EU_IPFF Scientific Advisory Board & co-chair of the Irish #raredisease CTN @rare_trial
Transplants of lung progenitor cells are safe in people with #COPD and show early signs of improving lung function and exercise capacity, according to results from a clinical trial involving patients with various stages of the disorder. #TongjiUniversity https://t.co/u02HE0CxLM
In press now with @AnnalsATS https://t.co/pG9JQx0fMd
CPAP but Not GLP1-mediated Weight Loss Improves Early Cardiovascular Disease in Obstructive Sleep Apnea: A Randomized Proof-of-Concept Study @ucddublin@UCD_Research@atscommunity@svuh
In press now at @ATSBlueEditor . International collaborative study on the prevalence of lymphangioleiomyomatosis #LAM in Europe, indicates much higher prevalence than previously reported. https://t.co/8GO4hsxEXK
RARE DISEASE CLINICAL TRIALS CONFERENCE 🔬🧬
Join global experts, researchers and advocates to explore the forefront of rare disease clinical research
📍The Grand Hotel, Malahide, Dublin, Ireland
🗓️ 29 Feb - 1 March 2024
👥 All welcome!
REGISTER HERE: https://t.co/aqxUbkunb4